Body adipose tissue depots and treatment outcomes for women with breast cancer: A systematic review.

BACKGROUND & AIMS: Excessive adipose tissue is associated with poorer prognosis in women with breast cancer (BC). However, several body adiposity depots, such as visceral (VAT), subcutaneous (SAT), intermuscular (IMAT), and gluteofemoral adipose tissues (GFAT) may have heterogeneous metabolic roles and health effects in these patients. This systematic review aims to evaluate the impact of different body adipose tissue depots, assessed via computed tomography (CT), on treatment outcomes for women with BC. We hypothesize that distinct body adipose tissue depots may be associated differently with outcomes in patients with BC. METHODS: A comprehensive bibliographical search was conducted using PubMed, Embase, Cochrane Library, Scopus, and Web of Science databases (until January 2024). The methodological quality of the included studies was assessed using the Newcastle-Ottawa Scale. RESULTS: The final sample comprised 23 retrospective studies (n = 12,462), with fourteen presenting good quality. A lack of standardization in CT body adipose tissue depots measurement and outcome presentation precluded quantitative analysis. Furthermore, most included studies had heterogeneous clinical characteristics. Survival and treatment response were the most prevalent outcomes. VAT (n = 19) and SAT (n = 17) were the most frequently evaluated depots and their increase was associated with worse outcomes, mainly in terms of survival. IMAT (n = 4) presented contradictory findings and a higher GFAT (n = 1) was associated with better outcomes. CONCLUSION: This systematic review found an association between increased VAT and SAT with worse outcomes in patients with BC. However, due to the heterogeneity of the included studies, further research with homogeneous methodologies is necessary to better understand the impact of body adipose tissue depots on treatment outcomes. Such knowledge could lead to improved care for this patient population.

Prevalence of thyroid dysfunction in neonates receiving parenteral nutrition in the intensive care unit

Abstract Objective: The use of parenteral nutrition (PN) formulations that do not contain iodine can contribute to the deficiency of this mineral, potentially leading to hypothyroidism and, ultimately, neurocognitive impairments. This study aimed to evaluate TSH alterations in newborns receiving PN. Methods: Retrospective study of neonatal intensive care unit patients receiving PN for > 15 days. Nutritional, anthropometric, and biochemical variables (TSH, T4, CRP) were analyzed. Hypothyroidism was defined by TSH > 10 mU/L. Results: Two hundred newborns were evaluated [156 (78%) preterm, 31±5 weeks of gestational age, 112 (56%) with very or extremely low birth weight]. The median (IQR) hospital stay was 68 (42-110) days, PN duration was 31 (21-47) days, and 188 (94%) patients also received enteral nutrition. Overall, 143 (71.5%) newborns underwent at least one TSH measurement. The prevalence of hypothyroidism was 10.5%. The Median PN duration in this group was 51 (34-109) days. Among those with hypothyroidism, 10 received Lugol's solution and six levothyroxine. Thirteen patients received prophylactic Lugol's solution with a median PN duration of 63 (48-197) days. TSH levels correlated positively with PN duration (r = 0.19, p = .02). Conclusions: The present data suggest that changes in TSH and T4 levels are present in neonates receiving PN for > 15 days, suggesting this population may be at risk for developing hypothyroid-ism. Therefore, the authors suggest that TSH and T4 measurements should be included as routine in neonatal patients receiving PN for > 15 days if PN formulations are not supplemented with iodine, and that iodine supplementation be provided as necessary.

Prevalence of thyroid dysfunction in neonates receiving parenteral nutrition in the intensive care unit.

OBJECTIVE: The use of parenteral nutrition (PN) formulations that do not contain iodine can contribute to the deficiency of this mineral, potentially leading to hypothyroidism and, ultimately, neurocognitive impairments. This study aimed to evaluate TSH alterations in newborns receiving PN. METHODS: Retrospective study of neonatal intensive care unit patients receiving PN for > 15 days. Nutritional, anthropometric, and biochemical variables (TSH, T4, CRP) were analyzed. Hypothyroidism was defined by TSH > 10 mU/L. RESULTS: Two hundred newborns were evaluated [156 (78%) preterm, 31±5 weeks of gestational age, 112 (56%) with very or extremely low birth weight]. The median (IQR) hospital stay was 68 (42-110) days, PN duration was 31 (21-47) days, and 188 (94%) patients also received enteral nutrition. Overall, 143 (71.5%) newborns underwent at least one TSH measurement. The prevalence of hypothyroidism was 10.5%. The Median PN duration in this group was 51 (34-109) days. Among those with hypothyroidism, 10 received Lugol's solution and six levothyroxine. Thirteen patients received prophylactic Lugol's solution with a median PN duration of 63 (48-197) days. TSH levels correlated positively with PN duration (r = 0.19, p = .02). CONCLUSIONS: The present data suggest that changes in TSH and T4 levels are present in neonates receiving PN for > 15 days, suggesting this population may be at risk for developing hypothyroidism. Therefore, the authors suggest that TSH and T4 measurements should be included as routine in neonatal patients receiving PN for > 15 days if PN formulations are not supplemented with iodine, and that iodine supplementation be provided as necessary.

Patients with enteral nutrition at risk of refeeding syndrome show electrolyte abnormalities at admission in the Emergency Department / Pacientes con nutrición enteral en riesgo de desarrollar síndrome de realimentación presentan trastornos electrolíticos al ingreso en el Servicio de Urgencias

Introduction: refeeding syndrome (RFS) is a metabolic complication in the initial phase of nutritional therapy (NT). Studies evaluating electrolyte abnormalities among patients at risk for RFS undergoing NT in the Emergency Department (ED) are scarce. Objective: to explore the occurrence of electrolyte abnormalities among patients at risk for RFS with enteral nutrition admitted to the ED. Material and methods: a retrospective cohort study that evaluated 440 adult patients undergoing NT, admitted to the ED of a public tertiary teaching hospital regarding RFS risk. Additional eligibility criteria included nutritional assessment by registered dietitians and at least one dose of an electrolyte (sodium, potassium, magnesium, phosphate, calcium) ordered by physicians. Differences were considered statistically significant at p < 0.05. Results: RFS risk criteria identified 83 (18.9 %) (65.1 % elderly, aged 64.2 ± 11.6 years, 65.1 % male; body mass index, 17.3 ± 3.5 kg/m²) patients at risk, of which 25 (30.1 %) had phosphorus, 48 (57.8 %) magnesium, and 60 (72.3 %) calcium dosages within the first week. All patients at risk for RFS had potassium and sodium evaluations. In those patients were serum levels were checked, hypophosphatemia was identified in 10 (40.0 %), hypomagnesemia in 12 (25.0 %) and hypokalemia in 13 (15.7 %) patients. Almost half of phosphorus assessments resulted from advice by registered dietitians to the staff. Conclusion: electrolyte evaluation was not ordered in all at-risk patients on NT. Despite the small sample, hypophosphatemia was a very common condition among this group. This study highlights the importance of RFS risk screening awareness among NT patients, and the important role of registered dietitians in this context. Larger sample studies are needed to confirm these results. (AU)

Introducción: el síndrome de realimentación (SR) es una complicación metabólica de la fase inicial del soporte nutricional (SN). Los estudios que evalúan trastornos electrolíticos en pacientes con riesgo de desarrollar SR y sometidos a NT en el servicio de Urgencias (SU) son escasos. Objetivo: explorar la aparición de trastornos electrolíticos en pacientes con riesgo de desarrollar SR con nutrición enteral, ingresados en Urgencias. Material y método: cohorte retrospectiva que evaluó 440 pacientes adultos con SN ingresados en el SU en cuanto al riesgo de desarrollar SR. Los criterios de elegibilidad fueron una evaluación nutricional por dietistas y al menos una dosis de un electrólito (sodio, potasio, magnesio, fosfato, cálcio) a petición de los médicos. Resultados: se identificaron 83 (18,9 %) pacientes con riesgo (65,1 % ancianos, edad de 64,2 ± 11,6 años, 65,1 % de varones; índice de masa corporal, 17,3 ± 3,5 kg/m²), de los que 25 (30,1 %) habían recibido dosis de fósforo, 48 (57,8 %) magnesio y 60 (72,3 %) calcio. Todos los pacientes tenían evaluaciones de potasio y sodio. Entre los pacientes en los que se midieron niveles séricos, se encontró hipofosfatemia en 10 (40,0 %), hipomagnesemia en 12 (25,0 %) e hipopotasemia en 13 (15,7 %). Aproximadamente, la mitad de las evaluaciones de fósforo se llevaron a cabo por consejo de los nutricionistas al personal médico. Conclusión: no se ordenó la evaluación de electrólitos en todos los pacientes con riesgo de SR en SN. A pesar de la pequeña muestra, la hipofosfatemia fue una condición muy común en este grupo. Este estudio destaca la importancia de la concienciación sobre el cribado del riesgo de SR en los pacientes con SN y el importante papel de los nutricionistas en este contexto. Se necesitan estudios con muestras grandes para confirmar estos resultados. (AU)

Patients with enteral nutrition at risk of refeeding syndrome show electrolyte abnormalities at admission in the Emergency Department.

INTRODUCTION: Introduction: refeeding syndrome (RFS) is a metabolic complication in the initial phase of nutritional therapy (NT). Studies evaluating electrolyte abnormalities among patients at risk for RFS undergoing NT in the Emergency Department (ED) are scarce. Objective: to explore the occurrence of electrolyte abnormalities among patients at risk for RFS with enteral nutrition admitted to the ED. Material and methods: a retrospective cohort study that evaluated 440 adult patients undergoing NT, admitted to the ED of a public tertiary teaching hospital regarding RFS risk. Additional eligibility criteria included nutritional assessment by registered dietitians and at least one dose of an electrolyte (sodium, potassium, magnesium, phosphate, calcium) ordered by physicians. Differences were considered statistically significant at p < 0.05. Results: RFS risk criteria identified 83 (18.9 %) (65.1 % elderly, aged 64.2 ± 11.6 years, 65.1 % male; body mass index, 17.3 ± 3.5 kg/m²) patients at risk, of which 25 (30.1 %) had phosphorus, 48 (57.8 %) magnesium, and 60 (72.3 %) calcium dosages within the first week. All patients at risk for RFS had potassium and sodium evaluations. In those patients were serum levels were checked, hypophosphatemia was identified in 10 (40.0 %), hypomagnesemia in 12 (25.0 %) and hypokalemia in 13 (15.7 %) patients. Almost half of phosphorus assessments resulted from advice by registered dietitians to the staff. Conclusion: electrolyte evaluation was not ordered in all at-risk patients on NT. Despite the small sample, hypophosphatemia was a very common condition among this group. This study highlights the importance of RFS risk screening awareness among NT patients, and the important role of registered dietitians in this context. Larger sample studies are needed to confirm these results.

INTRODUCCIÓN: Introducción: el síndrome de realimentación (SR) es una complicación metabólica de la fase inicial del soporte nutricional (SN). Los estudios que evalúan trastornos electrolíticos en pacientes con riesgo de desarrollar SR y sometidos a NT en el servicio de Urgencias (SU) son escasos. Objetivo: explorar la aparición de trastornos electrolíticos en pacientes con riesgo de desarrollar SR con nutrición enteral, ingresados en Urgencias. Material y método: cohorte retrospectiva que evaluó 440 pacientes adultos con SN ingresados en el SU en cuanto al riesgo de desarrollar SR. Los criterios de elegibilidad fueron una evaluación nutricional por dietistas y al menos una dosis de un electrólito (sodio, potasio, magnesio, fosfato, cálcio) a petición de los médicos. Resultados: se identificaron 83 (18,9 %) pacientes con riesgo (65,1 % ancianos, edad de 64,2 ± 11,6 años, 65,1 % de varones; índice de masa corporal, 17,3 ± 3,5 kg/m²), de los que 25 (30,1 %) habían recibido dosis de fósforo, 48 (57,8 %) magnesio y 60 (72,3 %) calcio. Todos los pacientes tenían evaluaciones de potasio y sodio. Entre los pacientes en los que se midieron niveles séricos, se encontró hipofosfatemia en 10 (40,0 %), hipomagnesemia en 12 (25,0 %) e hipopotasemia en 13 (15,7 %). Aproximadamente, la mitad de las evaluaciones de fósforo se llevaron a cabo por consejo de los nutricionistas al personal médico. Conclusión: no se ordenó la evaluación de electrólitos en todos los pacientes con riesgo de SR en SN. A pesar de la pequeña muestra, la hipofosfatemia fue una condición muy común en este grupo. Este estudio destaca la importancia de la concienciación sobre el cribado del riesgo de SR en los pacientes con SN y el importante papel de los nutricionistas en este contexto. Se necesitan estudios con muestras grandes para confirmar estos resultados.

Nitrogen balance in mechanically ventilated obese patients / Balanço nitrogenado em pacientes obesos em ventilação mecânica invasiva

ABSTRACT Objective This study aimed to evaluate if the protein intake recommendations for obese critically ill requiring mechanical ventilation are sufficient to promote a positive or neutral nitrogen balance. Methods Cross-sectional study that included 25 obese, ≥18 years old, undergoing mechanical ventilation and who were target to receive high-protein enteral nutrition therapy (2.0-2.5g/kg ideal body weight). Clinical, nutritional and biochemical variables were analyzed. Nitrogen balance was performed when patient was receiving full enteral nutrition therapy and was classified: positive when intake was greater than excretion; negative when excretion was greater than intake; neutral when both were equal. Results The characteristics of patients evaluated were 64.1±9.4 years old, clinical treatment 88%, body mass index 36.5±5.1kg/m2, nitrogen balance 0.3g/day (-5.3 to 4.8g/day), protein intake 2.1g/day (2.0-2.3g/kg) ideal body weight. Of individuals analyzed, 52% showed positive or neutral nitrogen balance with median of 4.23g/day 2.41 to 6.40g/day) in comparison to negative group with median of -5.27g/day (-10.38 to -3.86g/day). Adults had higher ratio of negative nitrogen balance (57.1%) than elderly (44.4%), with protein intake of 2.0 versus 2.1g/day, respectively. No correlation was found between nitrogen balance and variables assessed. Conclusion High-protein enteral nutrition therapy contributed to positive or neutral nitrogen balance for approximately half of obese ventilated individuals. With similar protein intake, elderly showed a higher proportion of positive or neutral nitrogen balance. Nitrogen balance can be influenced by various factors, so further studies are required to identify different protein needs in obese critically.

RESUMO Objetivo Avaliar se as recomendações de ingestão proteica para obesos em ventilação mecânica invasiva são suficientes para promover balanço nitrogenado positivo ou em equilíbrio. Métodos Estudo transversal que analisou 25 obesos adultos, em ventilação mecânica invasiva e submetidos à terapia nutricional enteral hiperproteica (2,0-2,5g/kg de peso ideal). Variáveis clínicas, nutricionais e bioquímicas foram analisadas. O balanço nitrogenado foi realizado após a oferta plena da nutrição enteral e classificado como: positivo quando ingestão maior que excreção; negativo quando excreção maior que ingestão; neutro quando ambas foram iguais. Resultados As características dos pacientes avaliados foram idade 64,1±9,4 anos, índice de massa corporal 36,5±5,1kg/m2, tratamento clínico 88%, balanço nitrogenado 0,3g/dia (-5,3 a 4,8g/dia), ingestão proteica 2,1g/dia (2,0-2,3g/kg) de peso ideal. Dos indivíduos analisados, 52% apresentaram balanço nitrogenado positivo ou neutro com mediana de 4,23g/dia (2,41 a 6,40g/dia), comparado ao grupo com balanço negativo -5,27g/dia (-10,38 a -3,86g/dia). Adultos apresentaram maior proporção de balanço nitrogenado negativo (57,1%) do que idosos (44,4%), respectivamente, com ingestão proteica semelhante de 2,0 versus 2,1g/dia. Não foi observada correlação entre balanço nitrogenado e variáveis analisadas. Conclusão A terapia nutricional enteral hiperproteica promoveu um balanço nitrogenado positivo ou neutro em cerca de metade dos obesos em ventilação mecânica invasiva. Com ingestão proteica semelhante, idosos apresentaram maior proporção de balanço positivo ou neutro do que adultos. O balanço nitrogenado pode ser influenciado por diversos fatores e por esse motivo mais estudos são necessários para identificar diferentes necessidades proteicas em pacientes obesos críticos.

Análise da densidade mineral óssea em pacientes com fenilcetonúria e sua correlação com parâmetros nutricionais / Bone mineral density assessment in patients with phenylketonuria and its correlation with nutritional parameters

Introdução: Redução da densidade mineral óssea (DMO) está associada à Fenilcetonúria (PKU), mas a causa desta associação não é completamente entendida. O objetivo desse estudo foi avaliar a ingestão de nutrientes relacionados ao metabolismo ósseo (cálcio, fósforo, magnésio, potássio), e sua associação com a DMO em pacientes com PKU. Métodos: Estudo transversal, observacional. Foram incluídos 15 pacientes (PKU Clássica=8; Leve=7; mediana de idade=16 anos, IQ=15-20), todos em tratamento com dieta restrita em fenilalanina (Phe) e 13 em uso de fórmula metabólica. Foi realizado recordatório alimentar de 24 horas de um dia e demais dados (histórico de fraturas, parâmetros antropométricos, DMO e níveis plasmáticos de Phe, Tyr, cálcio) foram obtidos por revisão de prontuário. Resultados: Nenhum paciente apresentou histórico de fraturas e seis realizavam suplementação de cálcio (alteração prévia da DMO=5; baixa ingestão=1). A mediana dos níveis de Phe foi 11,6 mg/dL (IQ=9,3-13,3). Em relação ao recordatório alimentar, dez indivíduos apresentaram inadequado consumo de carboidratos; 14, de lipídeos; 9, de cálcio; 11, de magnésio; 13, de fósforo; e todos de potássio. A mediana da DMO foi de 0,989 g/cm2 (IQ=0,903-1,069), sendo duas classificadas como reduzidas para idade, ambas de pacientes com PKU Leve que recebiam suplementação de cálcio. Não foi observada correlação entre níveis de Phe, DMO e demais variáveis analisadas. Conclusão: Redução da DMO não foi frequente na amostra, embora ingestão inadequada de cálcio assim o seja. Estudos adicionais são necessários para esclarecer o efeito da Phe e da ingestão dietética sobre o metabolismo ósseo na PKU. (AU)

Introduction: Reduced bone mineral density (BMD) is associated with phenylketonuria (PKU), but this association is not completely understood. This research aimed to evaluate intake of nutrients related to bone metabolism (calcium, phosphorus, magnesium, potassium) and its association with BMD in patients with PKU. Methods: In this cross-sectional, observational study, 15 patients with PKU (Classical=8, Mild=7; median age=16 years, IQ=15-20 years) were included, all of them on phenylalanine (Phe) restricted diet and 13 being supplemented with a metabolic formula. A 24-hour dietary recall was performed and remaining data (history of fractures, anthropometric parameters, BMD and plasma Phe, tyrosine and calcium levels) were obtained through medical chart review. Results: No patient had any fractures and six received calcium supplements, five due to previous change in BMD and one due to inadequate nutritional intake. Median Phe level was 11.6 mg/dL (IQ=9.3-13.3). In relation to dietary recall, all individuals had inadequate intake of some nutrient (carbohydrate=10; lipids=14; calcium=9; magnesium=11; phosphorus=13; potassium=15). The median BMD was 0.989 g/cm2 (IQ=0.903-1.069). Two cases were classified as low BMD for age, both in patients with mild PKU receiving calcium supplements. Conclusion: Reduced BMD was not common in this sample, although inadequate calcium intake was frequently reported. Additional studies are needed to clarify the effect of Phe and dietary intake on bone metabolism in patients with PKU.(AU)